Details of Disease

Disease Name

Arthralgia

Disease Class

ME82: Joint pain

Disease Hierarchy

DIS01GPL: Grass pollen hypersensitivity

DISF68US: Arthralgia

ICD-11

ICD-11: ME82

ICD-10

ICD-10: M25.5

Expand ICD-11

'ME82

Expand ICD-10

'M25.5

Disease Identifiers

MONDO ID

MONDO_0005178

MESH ID

D010003

UMLS CUI

C0029408

MedGen ID

45244

HPO ID

HP:0002758

SNOMED CT ID

225655006

General Information of Disease (ID: DISF68US)

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)

This Disease is Treated as An Indication in 3 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Fulranumab	DMK38MV	Phase 3	Monoclonal antibody	[1]
PG-201	DMTBXZM	Phase 3	NA	[2]
CE-224535	DMFCLT6	Phase 2/3	Small molecular drug	[3]
------------------------------------------------------------------------------------

This Disease is Treated as An Indication in 1 Discontinued Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
CJ-23423	DM2OC8E	Discontinued in Phase 2	NA	[4]
------------------------------------------------------------------------------------

This Disease is Treated as An Indication in 1 Preclinical Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
BN-GU-005-DHP	DM0PJU9	Preclinical	NA	[5]
------------------------------------------------------------------------------------

This Disease is Treated as An Indication in 1 Investigative Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
CNSB-006	DM4WFJQ	Investigative	NA	[6]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1	ClinicalTrials.gov (NCT02336685) Study of Efficacy, Safety of Fulranumab Adjunctive Use in OA of Hip or Knee, PAI3001. U.S. National Institutes of Health.
2	ClinicalTrials.gov (NCT01576419) Active Drug Comparative, Multi-center, phase3 Clinical Study to Evaluate the Efficacy and Safety of PG201 in Osteoarthritis Patients. U.S. National Institutes of Health.
3	ClinicalTrials.gov (NCT00628095) Study of CE-224,535 A Twice Daily Pill To Control Rheumatoid Arthritis In Patients Who Have Not Totally Improved With Methotrexate. U.S. National Institutes of Health.
4	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025514)
5	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800023897)
6	The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.